Senti Biosciences, Inc

Call
Website
2 Corporate Dr Ste 1
South San Francisco, CA 94080
+1 (650) 239-2030
https://www.sentibio.com

Senti Biosciences, Inc. is a clinical-stage biotechnology company based in South San Francisco, CA, that focuses on developing innovative cancer therapeutics utilizing synthetic biology. Through its proprietary Gene Circuit technology, Senti Bio designs and optimizes biological systems that enable cells to sense their environment, compute decisions, and deliver targeted treatments, aiming to kill cancer cells while sparing healthy tissue.

The company's lead product candidate, SENTI-202, is currently in clinical trials for the treatment of acute myeloid leukemia (AML). With a commitment to advancing cell therapy programs, Senti Bio is dedicated to addressing significant challenges in oncology and providing potentially lifesaving solutions for patients with incurable diseases.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Vaxart, Inc

Nabi Biopharmaceuticals develops and markets products that fight serious medical conditions. The company focuses on developing products that address commercial opportunities. Its main business areas encompass Gram-positive bacterial infections, hepatitis, kidney disease and nicotine addiction. Nabi Biopharmaceuticals product brands include PhosLo, Nabi-HB and Aloprim along with a number of products in various stages of clinical and pre-clinical development. Nabi Biopharmaceuticals maintains its international headquarters in Boca Raton, Fla., with principal research and development offices and laboratories in Rockville, Md. The company's European headquarters, Nabi Biopharmaceuticals Europe Limited, is located in Bray, Ireland.
Drugs acting on the respiratory system

BlackThorn Therapeutics

Gilead Sciences, Inc
Drugs acting on the respiratory system, Blood derivatives

Gilead Sciences, Inc

Founded in 1987, Gilead Sciences is one of the leaders in the discovery and development of a new class of human therapeutics based on nucleotides, the building blocks of DNA and RNA in the United States. The company discovers, develops and commercializes medications to advance the care of patients suffering from life-threatening diseases. Headquartered in Foster City, Calif., it serves North America, Europe and Australia and employs a staff of more than 3,400 individuals. Gilead Sciences areas of focus include antivirals, such as HIV/AIDS and chronic hepatitis, as well as cardiovascular conditions, including pulmonary arterial hypertension and resistant hypertension. The company also conducts studies on various respiratory diseases, such as influenza and cystic fibrosis.
United States›California›South San Francisco›Senti Biosciences, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.